MichaelEricZegansMD
Ophthalmology • Lebanon, NHCataract Related, Cornea & External Disease, Retinal Disease
Professor, Surgery, Geisel School of Medicine
Are you Dr. Zegans?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
# Section
Lebanon, NH 03756Phone+1 603-650-5123
Summary
- Dr. Michael Zegans, MD is a board certified ophthalmologist in Lebanon, New Hampshire. He is currently licensed to practice medicine in New Hampshire, Vermont, and California. He is affiliated with Dartmouth-Hitchcock Medical Center and White River Junction Veterans Affairs Medical Center.
Education & Training
University of Virginia Medical CenterResidency, Ophthalmology, 1993 - 1996
University of California (San Francisco)Internship, Internal Medicine, 1992 - 1993- University of California San Francisco School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1996 - Present
NH State Medical License 1998 - 2026
VT State Medical License 2024 - 2024- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- 56 citationsInfectious corneal ulceration: a proposal for neglected tropical disease status.Lawson Ung, Nisha R. Acharya, Tushar Agarwal, Eduardo C. Alfonso, Bhupesh Bagga
Bulletin of the World Health Organization. 2019-12-01 - 1 citationsCefiderocol is an effective topical monotherapy for experimental extensively-drug resistantkeratitis.Eric G Romanowski, Sonya M Mumper, Hazel Q Shanks, Kathleen A Yates, Jonathan B Mandell
Biorxiv. 2023-09-02 - 1 citationsCefiderocol Is an Effective Topical Monotherapy for Experimental Extensively Drug-ResistantKeratitis.Eric G Romanowski, Sonya M Mumper, Hazel Q Shanks, Kathleen A Yates, Jonathan B Mandell
Ophthalmology Science. 2023-12-13
Press Mentions
Association of Biofilm Formation, Psl EPS Expression, and Clinical Outcomes in P Aeruginosa KeratitisFebruary 4th, 2016
Morbidity and Mortality Weekly ReportFebruary 21st, 2003
Grant Support
- Biofilm Formation And P. Aeruginosa Infection Of The EyeNational Eye Institute2002–2006
Professional Memberships
- Fellow
